新生儿及6月龄以下婴儿全麻诱导后低血压麻黄碱有效剂量研究
该多中心随机对照开放标签剂量递增试验纳入119例6月龄以下婴儿,探究七氟烷全麻诱导后低血压时麻黄碱的最佳剂量。结果显示最佳剂量为1.2 mg kg-1,成功率为65.5%(95%CI 35.6-86.4),研究剂量未引起不良事件。结论认为新生儿和婴儿所需麻黄碱剂量约为成人的10倍。
要点
- 新生儿及6月龄以下婴儿全麻诱导后低血压时麻黄碱最佳剂量为1.2 mg kg-1。
- 该剂量下10分钟内MAP恢复至基线80%以上的成功率为65.5%。
- 研究剂量范围内未观察到不良事件。
核心结论
- 新生儿及6月龄以下婴儿七氟烷全麻诱导后低血压需使用约为成人10倍剂量的麻黄碱。
研究设计与样本
- 多中心、前瞻性、随机、开放标签、对照、剂量递增试验,共纳入119例婴儿(女性25%),平均年龄2.7(标准差1.3)个月。
- 共6个队列,每队列20例;首队列10例接受0.1 mg kg-1静脉注射(参考剂量),后续队列依次递增至0.6、0.8、1、1.2、1.4 mg kg-1。
主要发现
- 麻黄碱最佳剂量为1.2 mg kg-1,10分钟内MAP至少一次恢复至基线80%以上的成功率为65.5%(95%CI 35.6-86.4)。
- 研究所用剂量未引起不良事件。
关键数值与推荐
- 纳入标准为MAP较基线变化>20%的婴儿。
- 主要结局为给药后10分钟内MAP至少一次恢复至基线80%以上。
临床怎么用
- 对6月龄以下婴儿七氟烷全麻诱导后低血压,可考虑使用远高于成人推荐量的麻黄碱(最佳1.2 mg kg-1静脉注射)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The recommended dose of ephedrine in adults (0.1 mg kg-1) frequently fails to treat hypotension after induction of general anaesthesia in neonates and infants less than 6 months of age. The aim of this study was to determine the optimal dose of ephedrine in this population for the treatment of hypotension after induction of general anaesthesia with sevoflurane. METHODS: We conducted a multicentre, prospective, randomised, open-label, controlled, dose-escalation trial. Subjects were randomised if presenting a >20% change from baseline in MAP. Six cohorts of 20 subjects each were enrolled. Ten subjects in the first cohort received 0.1 mg kg-1 i. v. (reference dose). For each subsequent cohort, 10 subjects were assigned to the next higher dose (consecutively 0.6, 0.8, 1, 1.2, and 1.4 mg kg-1 i. v.), and the other subjects were assigned to one or more doses already investigated in previous cohorts. The primary outcome was the return of MAP to >80% of baseline at least once within 10 min after ephedrine administration. RESULTS: A total of 119 infants (25% females), with a mean age (standard deviation) of 2.7 (1.3) months, received their allocated dose of ephedrine. The optimal dose of ephedrine was 1.2 mg kg-1, with a percentage of success of 65.5% (95% confidence interval, 35.6-86.4). The doses of ephedrine investigated did not induce adverse events. CONCLUSIONS: Doses of ephedrine much higher (∼10-fold) than those used in adults are necessary in neonates and infants for the treatment of hypotension after induction of general anaesthesia with sevoflurane. CLINICAL TRIAL REGISTRATION: NCT02384876.
引用
- Szostek AS, Saunier C, Elsensohn MH, et al. Effective dose of ephedrine for treatment of hypotension after induction of general anaesthesia in neonates and infants less than 6 months of age: a multicentre randomised, controlled, open label, dose escalation trial. Br J Anaesth. 2023. PMID: 36639328. doi:10.1016/j.bja.2022.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。